P. Beato-Víbora

发表

Rapid improvement in time in range after the implementation of an advanced hybrid closed-loop system in adolescents and adults with type 1 diabetes.

P. Beato-Víbora, F. Gallego-Gamero, Ana Ambrojo-López, 2021, Diabetes technology & therapeutics.

Prospective analysis of the impact of commercialised hybrid closed-loop system on glycaemic control, glycaemic variability and patient-related outcomes in children and adults: a focus on superiority over predictive low glucose suspend technology.

P. Beato-Víbora, F. J. Arroyo-Díez, Fabiola Gamero-Gallego, 2019, Diabetes technology & therapeutics.

The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy

P. Beato-Víbora, Estela Gil-Poch, F. J. Arroyo-Díez, 2018, Journal of diabetes science and technology.

Iodine status and thyroid function among Spanish schoolchildren aged 6–7 years: the Tirokid study

P. Santiago, I. Velasco, C. Gutiérrez‐Repiso, 2016, British Journal of Nutrition.

Real-world outcomes with different technology modalities in type 1 diabetes.

P. Beato-Víbora, F. Gallego-Gamero, Ana Ambrojo-López, 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.

P. Beato-Víbora, 2020, Diabetes technology & therapeutics.

Glycemic control and insulin requirements in type 1 diabetic patients depending on the clinical characteristics at diabetes onset

P. Beato-Víbora, M. Á. Tormo-García, 2014, Endocrine research.

A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.

M. Giménez, J. Merino-Torres, G. Díaz-Soto, 2017, Diabetes research and clinical practice.

Continuous subcutaneous insulin infusion in type 1 diabetes mellitus patients: results from the Spanish national registry.

M. Vidal, A. Chico, J. Moreno-Fernandez, 2022, Diabetes technology & therapeutics.

Long-Term Survival of a Patient with Jejunal Somatostatin-Producing Tumour and Liver Metastases

R. Rodríguez-López, P. Beato-Víbora, J. R. Rodríguez-Mowbray, 2014 .

Spanish Translation and Linguistic Validation of the Glucose Monitoring Experiences Questionnaire (GME-Q) in Continuous Glucose Monitoring Users

P. Beato-Víbora, F. Gallego-Gamero, Ana Ambrojo-López, 2021, Journal of diabetes science and technology.

Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function

P. Beato-Víbora, F. J. Arroyo-Díez, 2018, Acta Diabetologica.

Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes

S. Amiel, P. Choudhary, H. Rogers, 2015, Diabetic medicine : a journal of the British Diabetic Association.

Avoiding Misdiagnosis Due to Antibody Interference with Serum Free Thyroxin

P. Beato-Víbora, S. Alejo-González, 2016, International journal of endocrinology and metabolism.

New uses and formulations of glucagon for hypoglycaemia

P. Beato-Víbora, F. J. Arroyo-Díez, 2019, Drugs in context.

Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.

P. Beato-Víbora, F. J. Arroyo-Díez, Lucía Lázaro-Martín, 2018, Diabetes technology & therapeutics.

Efficacy of insulin pump therapy in elderly patients.

S. Amiel, P. Choudhary, H. Rogers, 2015, Diabetes technology & therapeutics.

Iodine status and thyroid function among Spanish schoolchildren aged 6–7 years: the Tirokid study

C. Gutiérrez‐Repiso, E. García‐Fuentes, L. Vila, 2016, British Journal of Nutrition.